Koyfin Home > Directory > Health Care > Aimmune Therap > EV / EBITDA (ltm)

Aimmune Therap EV / EBITDA (ltm) Chart (AIMT)

Aimmune Therap annual/quarterly EV / EBITDA (ltm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Aimmune Therap Market Cap for the quarter ending March 03, 2018 was $1,841m a 43.79% increase of 806m year over year
  • Aimmune Therap Price / Book for the quarter ending March 03, 2018 was 9.15 a 57.27% increase of 5.24 year over year
  • Aimmune Therap Enterprise Value for the quarter ending March 03, 2018 was $1,659m a 52.45% increase of 870m year over year
View Chart On Koyfin